Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,205 | -115,346 | -173,799 | -49,501 | -22,826 |
| Depreciation Amortization | 1,048 | 457 | 1,531 | 1,113 | 743 |
| Other Working Capital | -2,011 | 899 | -1,412 | -1,379 | -3,193 |
| Other Operating Activity | 27,720 | 108,208 | 147,917 | 30,678 | 10,485 |
| Operating Cash Flow | $-14,448 | $-5,782 | $-25,763 | $-19,089 | $-14,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | -63 | -542 | -490 | -248 |
| Investing Cash Flow | $-80 | $-63 | $-542 | $-490 | $-248 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 0 | 25,000 | 25,000 | 10,000 |
| Common Stock Issued | 3,585 | 704 | 658 | N/A | 0 |
| Other Financing Activity | -63 | -63 | -46 | -46 | -14 |
| Financing Cash Flow | $28,522 | $641 | $25,612 | $24,954 | $9,986 |
| Beginning Cash Position | 14,078 | 14,078 | 14,771 | 14,771 | 14,771 |
| End Cash Position | 28,072 | 8,874 | 14,078 | 20,146 | 9,718 |
| Net Cash Flow | $13,994 | $-5,204 | $-693 | $5,375 | $-5,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,448 | -5,782 | -25,763 | -19,089 | -14,791 |
| Capital Expenditure | -80 | -63 | -542 | -490 | -248 |
| Free Cash Flow | -14,528 | -5,845 | -26,305 | -19,579 | -15,039 |